ICAM1 and renal fibrosis: Taken together with the changes in MAPK, NF-κB, and ICAM-1 molecules, it can be inferred that the beneficial effect of sRAGE on renal fibrosis was partly attributed to its inhibitory effect on these MAPK and subsequent inflammatory pathways.